$2.76
-0.04-1.43%
At close: -
$2.74
-0.02-0.72%
After Hours: Apr 25, 7:39 PM EDT
Comments
Loading...
Regulus Therapeutics Stock Guidance | NASDAQ:RGLS | Benzinga
Regulus Therapeutics issues guidance on future EPS and revenue, giving investors insight into how much the company expects to earn in upcoming periods.
| Get Alert | ||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
Regulus Therapeutics Inc (RGLS) does not provide guidance data | ||||||||||||
FAQ
What is the most recent guidance for Regulus Therapeutics (RGLS)?
There have been no specific sales or earnings guidance reported for Regulus Therapeutics in recent months.
Browse guidance and forecast on all stocks.
